Furthermore, western blotting and immunohistochemistry (IHC) staining results consistently showed that RBMS1 expression was lower in HCC tissues, particularly in higher T stage and advanced clinical TNM stage (Figure 1d-f). This evidence concerns the gene RBMS1 and hepatocellular carcinoma.